1.
Enugula VK, Shaik MY, M VPR, B NP, C SS. A Comparative Safety and Efficacy Study of Olmesrtan, a Newer Angiotensin-II Type-1 Receptor Blocker in Early Stage Type–2 Diabetes with Hypertension. JPBR [Internet]. 2016 Jun. 21 [cited 2026 Aug. 13];4(01):18-22. Available from: https://pharmaresearchlibrary.org/journals/index.php/jpbr/article/view/462